nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.221	0.534	CrCtD
Fludrocortisone—Progesterone—uterine cancer	0.192	0.466	CrCtD
Fludrocortisone—NR3C2—Progesterone—uterine cancer	0.0804	0.32	CbGbCtD
Fludrocortisone—AR—Medroxyprogesterone Acetate—uterine cancer	0.0629	0.25	CbGbCtD
Fludrocortisone—AR—Progesterone—uterine cancer	0.0417	0.166	CbGbCtD
Fludrocortisone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.04	0.159	CbGbCtD
Fludrocortisone—NR3C1—Progesterone—uterine cancer	0.0265	0.105	CbGbCtD
Fludrocortisone—Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.0167	0.0609	CrCrCtD
Fludrocortisone—Eplerenone—Progesterone—uterine cancer	0.0146	0.0531	CrCrCtD
Fludrocortisone—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.0133	0.0484	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.0127	0.0461	CrCrCtD
Fludrocortisone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.0127	0.0461	CrCrCtD
Fludrocortisone—Dydrogesterone—Progesterone—uterine cancer	0.0116	0.0422	CrCrCtD
Fludrocortisone—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.0116	0.0421	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Progesterone—uterine cancer	0.011	0.0402	CrCrCtD
Fludrocortisone—Spironolactone—Progesterone—uterine cancer	0.011	0.0402	CrCrCtD
Fludrocortisone—Megestrol acetate—Progesterone—uterine cancer	0.0101	0.0367	CrCrCtD
Fludrocortisone—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.00995	0.0362	CrCrCtD
Fludrocortisone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.0093	0.0338	CrCrCtD
Fludrocortisone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.00902	0.0328	CrCrCtD
Fludrocortisone—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.00899	0.0327	CrCrCtD
Fludrocortisone—Hydrocortamate—Progesterone—uterine cancer	0.00811	0.0295	CrCrCtD
Fludrocortisone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.00804	0.0292	CrCrCtD
Fludrocortisone—Cortisone acetate—Progesterone—uterine cancer	0.00786	0.0286	CrCrCtD
Fludrocortisone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.00783	0.0285	CrCrCtD
Fludrocortisone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.00783	0.0285	CrCrCtD
Fludrocortisone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.00764	0.0278	CrCrCtD
Fludrocortisone—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.00728	0.0265	CrCrCtD
Fludrocortisone—Fluoxymesterone—Progesterone—uterine cancer	0.00701	0.0255	CrCrCtD
Fludrocortisone—Testosterone Propionate—Progesterone—uterine cancer	0.00683	0.0248	CrCrCtD
Fludrocortisone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0068	0.0247	CrCrCtD
Fludrocortisone—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0068	0.0247	CrCrCtD
Fludrocortisone—Methyltestosterone—Progesterone—uterine cancer	0.00666	0.0242	CrCrCtD
Fludrocortisone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00639	0.0232	CrCrCtD
Fludrocortisone—Testosterone—Progesterone—uterine cancer	0.00593	0.0216	CrCrCtD
Fludrocortisone—Prednisolone—Progesterone—uterine cancer	0.0058	0.0211	CrCrCtD
Fludrocortisone—Hydrocortisone—Progesterone—uterine cancer	0.00557	0.0203	CrCrCtD
Fludrocortisone—AR—semen—uterine cancer	0.00221	0.132	CbGeAlD
Fludrocortisone—Glucose tolerance decreased—Progesterone—uterine cancer	0.00177	0.0542	CcSEcCtD
Fludrocortisone—AR—oviduct—uterine cancer	0.00162	0.0965	CbGeAlD
Fludrocortisone—Glucose tolerance decreased—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.0491	CcSEcCtD
Fludrocortisone—Benign intracranial hypertension—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.0335	CcSEcCtD
Fludrocortisone—Papilloedema—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.031	CcSEcCtD
Fludrocortisone—Osteonecrosis—Medroxyprogesterone Acetate—uterine cancer	0.000865	0.0265	CcSEcCtD
Fludrocortisone—NR3C2—myometrium—uterine cancer	0.000701	0.0417	CbGeAlD
Fludrocortisone—Hypernatraemia—Progesterone—uterine cancer	0.000676	0.0207	CcSEcCtD
Fludrocortisone—Menstruation irregular—Progesterone—uterine cancer	0.000642	0.0197	CcSEcCtD
Fludrocortisone—Hypernatraemia—Medroxyprogesterone Acetate—uterine cancer	0.000613	0.0188	CcSEcCtD
Fludrocortisone—Hirsutism—Progesterone—uterine cancer	0.000612	0.0187	CcSEcCtD
Fludrocortisone—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.000582	0.0178	CcSEcCtD
Fludrocortisone—Optic neuritis—Progesterone—uterine cancer	0.000578	0.0177	CcSEcCtD
Fludrocortisone—Osteoporosis—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.0176	CcSEcCtD
Fludrocortisone—Hirsutism—Medroxyprogesterone Acetate—uterine cancer	0.000554	0.017	CcSEcCtD
Fludrocortisone—NR3C2—uterine cervix—uterine cancer	0.000545	0.0324	CbGeAlD
Fludrocortisone—NR3C2—smooth muscle tissue—uterine cancer	0.00053	0.0315	CbGeAlD
Fludrocortisone—Optic neuritis—Medroxyprogesterone Acetate—uterine cancer	0.000524	0.016	CcSEcCtD
Fludrocortisone—AR—myometrium—uterine cancer	0.000519	0.0309	CbGeAlD
Fludrocortisone—NR3C2—renal system—uterine cancer	0.00051	0.0303	CbGeAlD
Fludrocortisone—Myopathy—Progesterone—uterine cancer	0.000507	0.0155	CcSEcCtD
Fludrocortisone—NR3C2—endometrium—uterine cancer	0.000493	0.0293	CbGeAlD
Fludrocortisone—NR3C2—mammalian vulva—uterine cancer	0.000477	0.0284	CbGeAlD
Fludrocortisone—NR3C2—uterus—uterine cancer	0.000454	0.027	CbGeAlD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—PAWR—uterine cancer	0.000411	0.0448	CbGpPWpGaD
Fludrocortisone—NR3C2—female reproductive system—uterine cancer	0.000409	0.0243	CbGeAlD
Fludrocortisone—AR—epithelium—uterine cancer	0.000407	0.0242	CbGeAlD
Fludrocortisone—Amenorrhoea—Progesterone—uterine cancer	0.000405	0.0124	CcSEcCtD
Fludrocortisone—AR—uterine cervix—uterine cancer	0.000404	0.024	CbGeAlD
Fludrocortisone—Glycosuria—Medroxyprogesterone Acetate—uterine cancer	0.000398	0.0122	CcSEcCtD
Fludrocortisone—AR—smooth muscle tissue—uterine cancer	0.000392	0.0233	CbGeAlD
Fludrocortisone—AR—decidua—uterine cancer	0.000385	0.0229	CbGeAlD
Fludrocortisone—AR—renal system—uterine cancer	0.000378	0.0225	CbGeAlD
Fludrocortisone—NR3C1—myometrium—uterine cancer	0.000376	0.0224	CbGeAlD
Fludrocortisone—NR3C2—female gonad—uterine cancer	0.000372	0.0221	CbGeAlD
Fludrocortisone—NR3C2—vagina—uterine cancer	0.000369	0.022	CbGeAlD
Fludrocortisone—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000367	0.0112	CcSEcCtD
Fludrocortisone—AR—endometrium—uterine cancer	0.000365	0.0217	CbGeAlD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000363	0.0395	CbGpPWpGaD
Fludrocortisone—AR—mammalian vulva—uterine cancer	0.000353	0.021	CbGeAlD
Fludrocortisone—Fluid retention—Progesterone—uterine cancer	0.000337	0.0103	CcSEcCtD
Fludrocortisone—AR—uterus—uterine cancer	0.000337	0.02	CbGeAlD
Fludrocortisone—NR3C2—Preimplantation Embryo—HMGA1—uterine cancer	0.000327	0.0356	CbGpPWpGaD
Fludrocortisone—Neoplasm—Progesterone—uterine cancer	0.000321	0.00984	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000319	0.0348	CbGpPWpGaD
Fludrocortisone—Fluid retention—Medroxyprogesterone Acetate—uterine cancer	0.000306	0.00936	CcSEcCtD
Fludrocortisone—AR—female reproductive system—uterine cancer	0.000303	0.018	CbGeAlD
Fludrocortisone—Thrombophlebitis—Progesterone—uterine cancer	0.000298	0.00912	CcSEcCtD
Fludrocortisone—Optic neuritis—Etoposide—uterine cancer	0.000296	0.00905	CcSEcCtD
Fludrocortisone—NR3C1—epithelium—uterine cancer	0.000295	0.0175	CbGeAlD
Fludrocortisone—NR3C1—uterine cervix—uterine cancer	0.000292	0.0174	CbGeAlD
Fludrocortisone—Neoplasm—Medroxyprogesterone Acetate—uterine cancer	0.000291	0.00891	CcSEcCtD
Fludrocortisone—Dydrogesterone—PGR—uterine cancer	0.000289	0.183	CrCbGaD
Fludrocortisone—Vascular purpura—Progesterone—uterine cancer	0.000288	0.00883	CcSEcCtD
Fludrocortisone—NR3C1—smooth muscle tissue—uterine cancer	0.000284	0.0169	CbGeAlD
Fludrocortisone—Injury—Progesterone—uterine cancer	0.000281	0.00859	CcSEcCtD
Fludrocortisone—Cardiomegaly—Epirubicin—uterine cancer	0.000279	0.00855	CcSEcCtD
Fludrocortisone—NR3C1—decidua—uterine cancer	0.000279	0.0166	CbGeAlD
Fludrocortisone—AR—female gonad—uterine cancer	0.000275	0.0164	CbGeAlD
Fludrocortisone—AR—vagina—uterine cancer	0.000274	0.0163	CbGeAlD
Fludrocortisone—NR3C1—renal system—uterine cancer	0.000274	0.0163	CbGeAlD
Fludrocortisone—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.00027	0.00827	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.000269	0.00823	CcSEcCtD
Fludrocortisone—Purpura—Progesterone—uterine cancer	0.000268	0.0082	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Progesterone—uterine cancer	0.000267	0.00816	CcSEcCtD
Fludrocortisone—NR3C1—endometrium—uterine cancer	0.000265	0.0157	CbGeAlD
Fludrocortisone—Cardiomegaly—Doxorubicin—uterine cancer	0.000258	0.00791	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.000258	0.00789	CcSEcCtD
Fludrocortisone—NR3C1—mammalian vulva—uterine cancer	0.000256	0.0152	CbGeAlD
Fludrocortisone—Affect lability—Progesterone—uterine cancer	0.000254	0.00777	CcSEcCtD
Fludrocortisone—Mood swings—Progesterone—uterine cancer	0.000244	0.00748	CcSEcCtD
Fludrocortisone—NR3C1—uterus—uterine cancer	0.000244	0.0145	CbGeAlD
Fludrocortisone—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.000243	0.00743	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.000242	0.0074	CcSEcCtD
Fludrocortisone—Infection—Carboplatin—uterine cancer	0.00024	0.00734	CcSEcCtD
Fludrocortisone—NR3C2—lymph node—uterine cancer	0.000239	0.0142	CbGeAlD
Fludrocortisone—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.00023	0.00705	CcSEcCtD
Fludrocortisone—Oesophagitis—Dactinomycin—uterine cancer	0.00023	0.00703	CcSEcCtD
Fludrocortisone—Abdominal distension—Progesterone—uterine cancer	0.000225	0.00687	CcSEcCtD
Fludrocortisone—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.000221	0.00678	CcSEcCtD
Fludrocortisone—NR3C1—female reproductive system—uterine cancer	0.000219	0.013	CbGeAlD
Fludrocortisone—Sweating increased—Progesterone—uterine cancer	0.000217	0.00665	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PGR—uterine cancer	0.000213	0.0232	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.000206	0.00631	CcSEcCtD
Fludrocortisone—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.000203	0.00623	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Progesterone—uterine cancer	0.000201	0.00616	CcSEcCtD
Fludrocortisone—NR3C1—female gonad—uterine cancer	0.000199	0.0119	CbGeAlD
Fludrocortisone—NR3C1—vagina—uterine cancer	0.000198	0.0118	CbGeAlD
Fludrocortisone—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00603	CcSEcCtD
Fludrocortisone—Hypernatraemia—Epirubicin—uterine cancer	0.000194	0.00593	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.000194	0.0211	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—ESR2—uterine cancer	0.000188	0.0204	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	0.000182	0.115	CrCbGaD
Fludrocortisone—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000182	0.00558	CcSEcCtD
Fludrocortisone—Haemoglobin—Progesterone—uterine cancer	0.000179	0.00549	CcSEcCtD
Fludrocortisone—Hypernatraemia—Doxorubicin—uterine cancer	0.000179	0.00549	CcSEcCtD
Fludrocortisone—Haemorrhage—Progesterone—uterine cancer	0.000178	0.00546	CcSEcCtD
Fludrocortisone—AR—lymph node—uterine cancer	0.000177	0.0105	CbGeAlD
Fludrocortisone—Megestrol acetate—PGR—uterine cancer	0.000174	0.11	CrCbGaD
Fludrocortisone—Skin hyperpigmentation—Epirubicin—uterine cancer	0.000171	0.00525	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000168	0.0183	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Etoposide—uterine cancer	0.000166	0.00509	CcSEcCtD
Fludrocortisone—Optic neuritis—Epirubicin—uterine cancer	0.000166	0.00507	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Etoposide—uterine cancer	0.000165	0.00506	CcSEcCtD
Fludrocortisone—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000163	0.00498	CcSEcCtD
Fludrocortisone—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000162	0.00495	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—PGR—uterine cancer	0.000162	0.0176	CbGpPWpGaD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—uterine cancer	0.000159	0.00485	CcSEcCtD
Fludrocortisone—Erythema—Progesterone—uterine cancer	0.000155	0.00476	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000155	0.0169	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	0.000154	0.0168	CbGpPWpGaD
Fludrocortisone—Optic neuritis—Doxorubicin—uterine cancer	0.000153	0.00469	CcSEcCtD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDH1—uterine cancer	0.000152	0.0166	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—HNF1B—uterine cancer	0.00015	0.0164	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000148	0.0161	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Etoposide—uterine cancer	0.000146	0.00446	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR2—uterine cancer	0.000142	0.0155	CbGpPWpGaD
Fludrocortisone—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000141	0.00431	CcSEcCtD
Fludrocortisone—Vertigo—Progesterone—uterine cancer	0.00014	0.00427	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Epirubicin—uterine cancer	0.000138	0.00422	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Etoposide—uterine cancer	0.000136	0.00417	CcSEcCtD
Fludrocortisone—Convulsion—Progesterone—uterine cancer	0.000135	0.00412	CcSEcCtD
Fludrocortisone—Hypertension—Progesterone—uterine cancer	0.000134	0.00411	CcSEcCtD
Fludrocortisone—Myalgia—Progesterone—uterine cancer	0.000132	0.00405	CcSEcCtD
Fludrocortisone—NR3C1—lymph node—uterine cancer	0.000128	0.00763	CbGeAlD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000128	0.0139	CbGpPWpGaD
Fludrocortisone—Dermatitis atopic—Doxorubicin—uterine cancer	0.000127	0.0039	CcSEcCtD
Fludrocortisone—Oedema—Progesterone—uterine cancer	0.000127	0.00388	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Progesterone—uterine cancer	0.000127	0.00388	CcSEcCtD
Fludrocortisone—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000127	0.00387	CcSEcCtD
Fludrocortisone—Infection—Progesterone—uterine cancer	0.000126	0.00386	CcSEcCtD
Fludrocortisone—Glycosuria—Epirubicin—uterine cancer	0.000126	0.00385	CcSEcCtD
Fludrocortisone—Petechiae—Epirubicin—uterine cancer	0.000124	0.00379	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Progesterone—uterine cancer	0.000123	0.00375	CcSEcCtD
Fludrocortisone—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.00373	CcSEcCtD
Fludrocortisone—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00012	0.00367	CcSEcCtD
Fludrocortisone—Glycosuria—Doxorubicin—uterine cancer	0.000116	0.00356	CcSEcCtD
Fludrocortisone—Amenorrhoea—Epirubicin—uterine cancer	0.000116	0.00355	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000116	0.00354	CcSEcCtD
Fludrocortisone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000115	0.00352	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000115	0.00352	CcSEcCtD
Fludrocortisone—Insomnia—Progesterone—uterine cancer	0.000115	0.00351	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—uterine cancer	0.000115	0.00351	CcSEcCtD
Fludrocortisone—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000114	0.00349	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—ESR1—uterine cancer	0.000114	0.0124	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000112	0.0122	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—uterine cancer	0.000112	0.0122	CbGpPWpGaD
Fludrocortisone—Sweating increased—Etoposide—uterine cancer	0.000111	0.0034	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000111	0.0034	CcSEcCtD
Fludrocortisone—Erythema—Dactinomycin—uterine cancer	0.00011	0.00336	CcSEcCtD
Fludrocortisone—Spironolactone—PGR—uterine cancer	0.000108	0.0684	CrCbGaD
Fludrocortisone—Amenorrhoea—Doxorubicin—uterine cancer	0.000107	0.00329	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000105	0.00321	CcSEcCtD
Fludrocortisone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000104	0.00318	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.000102	0.0111	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—PGR—uterine cancer	0.000101	0.0641	CrCbGaD
Fludrocortisone—AR—FOXA1 transcription factor network—ESR1—uterine cancer	0.000101	0.011	CbGpPWpGaD
Fludrocortisone—Urticaria—Progesterone—uterine cancer	0.000101	0.00308	CcSEcCtD
Fludrocortisone—Fluid retention—Epirubicin—uterine cancer	9.68e-05	0.00296	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—EZH2—uterine cancer	9.64e-05	0.0105	CbGpPWpGaD
Fludrocortisone—Myalgia—Dactinomycin—uterine cancer	9.35e-05	0.00286	CcSEcCtD
Fludrocortisone—Hypersensitivity—Progesterone—uterine cancer	9.34e-05	0.00286	CcSEcCtD
Fludrocortisone—Oesophagitis—Epirubicin—uterine cancer	9.31e-05	0.00285	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Epirubicin—uterine cancer	9.26e-05	0.00284	CcSEcCtD
Fludrocortisone—Ecchymosis—Epirubicin—uterine cancer	9.22e-05	0.00282	CcSEcCtD
Fludrocortisone—Neoplasm—Epirubicin—uterine cancer	9.22e-05	0.00282	CcSEcCtD
Fludrocortisone—Betamethasone—PGR—uterine cancer	9.2e-05	0.0582	CrCbGaD
Fludrocortisone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	9.13e-05	0.00279	CcSEcCtD
Fludrocortisone—Asthenia—Progesterone—uterine cancer	9.1e-05	0.00279	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	8.99e-05	0.00979	CbGpPWpGaD
Fludrocortisone—Oedema—Dactinomycin—uterine cancer	8.96e-05	0.00274	CcSEcCtD
Fludrocortisone—Fluid retention—Doxorubicin—uterine cancer	8.95e-05	0.00274	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IRF1—uterine cancer	8.92e-05	0.00971	CbGpPWpGaD
Fludrocortisone—Infection—Dactinomycin—uterine cancer	8.9e-05	0.00273	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	8.67e-05	0.00944	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—uterine cancer	8.63e-05	0.0094	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR1—uterine cancer	8.63e-05	0.0094	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Doxorubicin—uterine cancer	8.62e-05	0.00264	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Doxorubicin—uterine cancer	8.57e-05	0.00262	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Epirubicin—uterine cancer	8.55e-05	0.00262	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—uterine cancer	8.53e-05	0.00261	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—uterine cancer	8.53e-05	0.00261	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Epirubicin—uterine cancer	8.51e-05	0.0026	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—PHF1—uterine cancer	8.5e-05	0.00926	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	8.47e-05	0.00259	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	8.33e-05	0.00907	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Epirubicin—uterine cancer	8.27e-05	0.00253	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MSH2—uterine cancer	8.27e-05	0.009	CbGpPWpGaD
Fludrocortisone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	8.24e-05	0.00252	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	8.17e-05	0.0025	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Epirubicin—uterine cancer	8.16e-05	0.0025	CcSEcCtD
Fludrocortisone—Headache—Progesterone—uterine cancer	7.94e-05	0.00243	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—uterine cancer	7.91e-05	0.00242	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—uterine cancer	7.87e-05	0.00241	CcSEcCtD
Fludrocortisone—Purpura—Epirubicin—uterine cancer	7.68e-05	0.00235	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—uterine cancer	7.65e-05	0.00234	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—uterine cancer	7.64e-05	0.00234	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	7.61e-05	0.00828	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—uterine cancer	7.55e-05	0.00231	CcSEcCtD
Fludrocortisone—Fluoxymesterone—ESR1—uterine cancer	7.46e-05	0.0471	CrCbGaD
Fludrocortisone—Testosterone—CYP11A1—uterine cancer	7.34e-05	0.0464	CrCbGaD
Fludrocortisone—Affect lability—Epirubicin—uterine cancer	7.28e-05	0.00223	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—CHD4—uterine cancer	7.23e-05	0.00787	CbGpPWpGaD
Fludrocortisone—Headache—Medroxyprogesterone Acetate—uterine cancer	7.2e-05	0.0022	CcSEcCtD
Fludrocortisone—Vertigo—Etoposide—uterine cancer	7.14e-05	0.00219	CcSEcCtD
Fludrocortisone—Purpura—Doxorubicin—uterine cancer	7.1e-05	0.00217	CcSEcCtD
Fludrocortisone—Dexamethasone—CYP11A1—uterine cancer	7.1e-05	0.0449	CrCbGaD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—uterine cancer	7.07e-05	0.00217	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—SMAD3—uterine cancer	7.06e-05	0.00768	CbGpPWpGaD
Fludrocortisone—Mood swings—Epirubicin—uterine cancer	7.01e-05	0.00215	CcSEcCtD
Fludrocortisone—Convulsion—Etoposide—uterine cancer	6.89e-05	0.00211	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—CDKN1B—uterine cancer	6.88e-05	0.00749	CbGpPWpGaD
Fludrocortisone—Hypertension—Etoposide—uterine cancer	6.86e-05	0.0021	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR1—uterine cancer	6.82e-05	0.00743	CbGpPWpGaD
Fludrocortisone—Affect lability—Doxorubicin—uterine cancer	6.74e-05	0.00206	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—SMAD3—uterine cancer	6.64e-05	0.00723	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Dactinomycin—uterine cancer	6.6e-05	0.00202	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—YWHAE—uterine cancer	6.57e-05	0.00715	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—CYP19A1—uterine cancer	6.54e-05	0.0414	CrCbGaD
Fludrocortisone—Muscular weakness—Epirubicin—uterine cancer	6.53e-05	0.002	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CDKN1B—uterine cancer	6.52e-05	0.0071	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Etoposide—uterine cancer	6.49e-05	0.00199	CcSEcCtD
Fludrocortisone—Mood swings—Doxorubicin—uterine cancer	6.49e-05	0.00199	CcSEcCtD
Fludrocortisone—Infection—Etoposide—uterine cancer	6.44e-05	0.00197	CcSEcCtD
Fludrocortisone—Abdominal distension—Epirubicin—uterine cancer	6.44e-05	0.00197	CcSEcCtD
Fludrocortisone—Asthenia—Dactinomycin—uterine cancer	6.43e-05	0.00197	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—uterine cancer	6.4e-05	0.0404	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	6.32e-05	0.00688	CbGpPWpGaD
Fludrocortisone—Betamethasone—CYP19A1—uterine cancer	6.31e-05	0.0399	CrCbGaD
Fludrocortisone—Hyperhidrosis—Etoposide—uterine cancer	6.27e-05	0.00192	CcSEcCtD
Fludrocortisone—Pancreatitis—Epirubicin—uterine cancer	6.27e-05	0.00192	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PGR—uterine cancer	6.27e-05	0.00682	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	6.21e-05	0.00676	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ESR2—uterine cancer	6.06e-05	0.0066	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SUZ12—uterine cancer	6.06e-05	0.0066	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—HMGA1—uterine cancer	6.04e-05	0.00658	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—EP300—uterine cancer	6.04e-05	0.00658	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Doxorubicin—uterine cancer	6.04e-05	0.00185	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—uterine cancer	5.98e-05	0.00651	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Doxorubicin—uterine cancer	5.96e-05	0.00182	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	5.91e-05	0.00644	CbGpPWpGaD
Fludrocortisone—Progesterone—PGR—uterine cancer	5.85e-05	0.037	CrCbGaD
Fludrocortisone—Pancreatitis—Doxorubicin—uterine cancer	5.8e-05	0.00178	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	5.77e-05	0.00629	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Epirubicin—uterine cancer	5.77e-05	0.00177	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—EP300—uterine cancer	5.73e-05	0.00624	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	5.65e-05	0.00615	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—STK11—uterine cancer	5.65e-05	0.00615	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	5.56e-05	0.00605	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR2—uterine cancer	5.52e-05	0.00601	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—uterine cancer	5.47e-05	0.00596	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	5.46e-05	0.00594	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PGR—uterine cancer	5.35e-05	0.0338	CrCbGaD
Fludrocortisone—Hyperglycaemia—Doxorubicin—uterine cancer	5.34e-05	0.00163	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ESR1—uterine cancer	5.29e-05	0.00576	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	5.26e-05	0.00573	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—EP300—uterine cancer	5.2e-05	0.00567	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	5.15e-05	0.00561	CbGpPWpGaD
Fludrocortisone—Urticaria—Etoposide—uterine cancer	5.15e-05	0.00158	CcSEcCtD
Fludrocortisone—Haemoglobin—Epirubicin—uterine cancer	5.14e-05	0.00157	CcSEcCtD
Fludrocortisone—Haemorrhage—Epirubicin—uterine cancer	5.12e-05	0.00157	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CTNNB1—uterine cancer	5e-05	0.00545	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	4.98e-05	0.00542	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—uterine cancer	4.83e-05	0.00526	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	4.81e-05	0.00524	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Etoposide—uterine cancer	4.78e-05	0.00146	CcSEcCtD
Fludrocortisone—Haemoglobin—Doxorubicin—uterine cancer	4.76e-05	0.00146	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—uterine cancer	4.74e-05	0.00145	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	4.71e-05	0.00513	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.68e-05	0.0051	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCL2—uterine cancer	4.66e-05	0.00507	CbGpPWpGaD
Fludrocortisone—Asthenia—Etoposide—uterine cancer	4.65e-05	0.00142	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ESR2—uterine cancer	4.6e-05	0.00501	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SOCS3—uterine cancer	4.52e-05	0.00493	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CDKN2B—uterine cancer	4.49e-05	0.00489	CbGpPWpGaD
Fludrocortisone—Erythema—Epirubicin—uterine cancer	4.46e-05	0.00136	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	4.36e-05	0.00475	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.2e-05	0.00457	CbGpPWpGaD
Fludrocortisone—Erythema—Doxorubicin—uterine cancer	4.12e-05	0.00126	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SMAD3—uterine cancer	4.1e-05	0.00447	CbGpPWpGaD
Fludrocortisone—Headache—Etoposide—uterine cancer	4.06e-05	0.00124	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—uterine cancer	4.06e-05	0.00442	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	4.03e-05	0.00438	CbGpPWpGaD
Fludrocortisone—Vertigo—Epirubicin—uterine cancer	4e-05	0.00123	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—SMAD3—uterine cancer	3.95e-05	0.0043	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—EP300—uterine cancer	3.95e-05	0.0043	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PHF1—uterine cancer	3.95e-05	0.0043	CbGpPWpGaD
Fludrocortisone—Convulsion—Epirubicin—uterine cancer	3.86e-05	0.00118	CcSEcCtD
Fludrocortisone—Hypertension—Epirubicin—uterine cancer	3.85e-05	0.00118	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—EP300—uterine cancer	3.83e-05	0.00417	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP19A1—uterine cancer	3.79e-05	0.024	CrCbGaD
Fludrocortisone—Myalgia—Epirubicin—uterine cancer	3.79e-05	0.00116	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.77e-05	0.00411	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	3.74e-05	0.00408	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	3.71e-05	0.00404	CbGpPWpGaD
Fludrocortisone—Vertigo—Doxorubicin—uterine cancer	3.7e-05	0.00113	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	3.7e-05	0.00403	CbGpPWpGaD
Fludrocortisone—Progesterone—ESR1—uterine cancer	3.69e-05	0.0234	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—uterine cancer	3.68e-05	0.00401	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP19A1—uterine cancer	3.67e-05	0.0232	CrCbGaD
Fludrocortisone—Anaphylactic shock—Epirubicin—uterine cancer	3.64e-05	0.00111	CcSEcCtD
Fludrocortisone—Oedema—Epirubicin—uterine cancer	3.64e-05	0.00111	CcSEcCtD
Fludrocortisone—Infection—Epirubicin—uterine cancer	3.61e-05	0.00111	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	3.6e-05	0.00392	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	3.6e-05	0.00392	CbGpPWpGaD
Fludrocortisone—Convulsion—Doxorubicin—uterine cancer	3.57e-05	0.00109	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—uterine cancer	3.56e-05	0.00109	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Epirubicin—uterine cancer	3.52e-05	0.00108	CcSEcCtD
Fludrocortisone—Myalgia—Doxorubicin—uterine cancer	3.51e-05	0.00107	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	3.48e-05	0.00379	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EP300—uterine cancer	3.44e-05	0.00374	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	3.4e-05	0.0037	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Doxorubicin—uterine cancer	3.36e-05	0.00103	CcSEcCtD
Fludrocortisone—Oedema—Doxorubicin—uterine cancer	3.36e-05	0.00103	CcSEcCtD
Fludrocortisone—AR—Gene Expression—CHD4—uterine cancer	3.36e-05	0.00365	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—uterine cancer	3.35e-05	0.00364	CbGpPWpGaD
Fludrocortisone—Infection—Doxorubicin—uterine cancer	3.34e-05	0.00102	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	3.31e-05	0.00361	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—uterine cancer	3.31e-05	0.00101	CcSEcCtD
Fludrocortisone—Insomnia—Epirubicin—uterine cancer	3.29e-05	0.00101	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	3.28e-05	0.00357	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Doxorubicin—uterine cancer	3.25e-05	0.000996	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	3.25e-05	0.00354	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	3.16e-05	0.00344	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.13e-05	0.0034	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	3.07e-05	0.000938	CcSEcCtD
Fludrocortisone—Insomnia—Doxorubicin—uterine cancer	3.04e-05	0.000932	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—PGR—uterine cancer	3.02e-05	0.00329	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PHF1—uterine cancer	2.99e-05	0.00326	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PGR—uterine cancer	2.91e-05	0.00317	CbGpPWpGaD
Fludrocortisone—Urticaria—Epirubicin—uterine cancer	2.89e-05	0.000884	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—EZH2—uterine cancer	2.87e-05	0.00312	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	2.81e-05	0.00306	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SUZ12—uterine cancer	2.81e-05	0.00306	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	2.81e-05	0.00306	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	2.78e-05	0.00303	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	2.77e-05	0.00301	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Epirubicin—uterine cancer	2.68e-05	0.00082	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—uterine cancer	2.67e-05	0.000818	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—ESR2—uterine cancer	2.66e-05	0.00289	CbGpPWpGaD
Fludrocortisone—Asthenia—Epirubicin—uterine cancer	2.61e-05	0.000799	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—ESR2—uterine cancer	2.56e-05	0.00279	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	2.56e-05	0.00279	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CHD4—uterine cancer	2.55e-05	0.00277	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Doxorubicin—uterine cancer	2.48e-05	0.000759	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.42e-05	0.00264	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—uterine cancer	2.41e-05	0.000739	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.36e-05	0.00257	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.36e-05	0.00257	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.29e-05	0.0025	CbGpPWpGaD
Fludrocortisone—Headache—Epirubicin—uterine cancer	2.28e-05	0.000697	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	2.26e-05	0.00246	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.25e-05	0.00245	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.24e-05	0.00244	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	2.21e-05	0.0024	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	2.19e-05	0.00239	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CDKN2B—uterine cancer	2.16e-05	0.00235	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SUZ12—uterine cancer	2.13e-05	0.00232	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.13e-05	0.00232	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.12e-05	0.00231	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—uterine cancer	2.11e-05	0.000645	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	2.08e-05	0.00227	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.08e-05	0.00226	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	2.08e-05	0.00226	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CTNNB1—uterine cancer	2.07e-05	0.00226	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.01e-05	0.00219	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	1.99e-05	0.00217	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SMAD3—uterine cancer	1.97e-05	0.00215	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.96e-05	0.00213	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	1.94e-05	0.00212	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.94e-05	0.00211	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SMAD3—uterine cancer	1.9e-05	0.00207	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.87e-05	0.00203	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.81e-05	0.00197	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.79e-05	0.00195	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.77e-05	0.00192	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.7e-05	0.00185	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	1.68e-05	0.00183	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	1.66e-05	0.00181	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.61e-05	0.00175	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—uterine cancer	1.61e-05	0.00175	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.58e-05	0.00172	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.58e-05	0.00172	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—uterine cancer	1.55e-05	0.00169	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.5e-05	0.00164	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	1.44e-05	0.00157	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PGR—uterine cancer	1.4e-05	0.00152	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.38e-05	0.0015	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.36e-05	0.00148	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.34e-05	0.00145	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EZH2—uterine cancer	1.33e-05	0.00145	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR2—uterine cancer	1.23e-05	0.00134	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	1.18e-05	0.00128	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.13e-05	0.00123	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PGR—uterine cancer	1.06e-05	0.00116	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EZH2—uterine cancer	1.01e-05	0.0011	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CDKN2B—uterine cancer	1e-05	0.00109	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR2—uterine cancer	9.35e-06	0.00102	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SMAD3—uterine cancer	9.16e-06	0.000998	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CDKN2B—uterine cancer	7.61e-06	0.000829	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—uterine cancer	7.48e-06	0.000814	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SMAD3—uterine cancer	6.95e-06	0.000757	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—uterine cancer	5.81e-06	0.000633	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—uterine cancer	5.67e-06	0.000618	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—uterine cancer	2.7e-06	0.000294	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—uterine cancer	2.05e-06	0.000223	CbGpPWpGaD
